Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Hair color loss can indicate the effectiveness of a drug targeting the KIT protein in mice and humans.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

Baricitinib effectively promotes regrowth of eyebrows and eyelashes in alopecia areata patients.

Baricitinib helped regrow hair in patients with severe alopecia areata after other treatments failed.

Rapamycin reduces skin cell growth and tumor development by affecting cell signaling in mice.

Ritlecitinib is an effective new treatment for Alopecia Areata.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

Tofacitinib helped a woman regrow hair with no major side effects.

Tofacitinib and baricitinib are similarly effective and safe for alopecia areata, but baricitinib works faster.

Gefitinib can cause scalp skin issues and permanent hair loss.

Immunotherapy with pembrolizumab significantly reduced cancer in a young woman with adrenocortical carcinoma.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Ritlecitinib can help about 14,000 people with severe hair loss.

Cepharanthine shows promise as a natural anticancer treatment.

Ruxolitinib helped a woman with a genetic mutation regrow her hair and improved her health.

Topical metformin may improve hair regrowth in CCCA when added to standard treatments.

Bicalutamide, a drug with a good safety profile, is a promising new treatment for female pattern hair loss.

Aminopterin was somewhat effective in acute lymphoblastic leukemia in children but did not increase survival time.

Newly made nicotinamide compounds could potentially treat cancer.

Baricitinib effectively regrows hair in severe alopecia areata cases.

Ritlecitinib works well and is safe for treating alopecia areata.

The study found two new mutations in a Chinese patient with severe biotinidase deficiency.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.